EIM
FOMX

Essex Investment Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Essex Investment Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-78,136
Closed -$401K – 441
2018
Q1 		$401K Buy
+78,136
New +$470K 0.05% 283

Other funds holding FOMX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Essex Investment Management's FOMX Position: Q2 2018 in Review

Essex Investment Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q2 2018, closing a stake of 78,136 shares — an estimated $401K sold.

Essex Investment Management first reported a position in FOMX in Q1 2018 and held it in 1 quarter. The position peaked at $401K in Q1 2018. 56 funds tracked by Wall St. Rank hold FOMX as of Q2 2018.

  • Essex Investment Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q2 2018 after selling out during the quarter.
  • Essex Investment Management sold 78,136 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q2 2018, an estimated $401K.
  • Essex Investment Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2018 and held it in 1 quarter.
  • Essex Investment Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $401K in Q1 2018.
  • 56 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q2 2018.

Based on Essex Investment Management's 13F filing for Q2 2018, filed 17 Jul 2018.